Arkolith/Insider Trading/AURX/Form 4/A

Jorden David Emerson

CEO/CFO, DirectorNuo Therapeutics, Inc. (AURX) · full profile →Form 4/A · filed Aug 31, 2026
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 28, 2026Buy(P)8K$1.09$9K2.1M
Aug 27, 2026Buy(P)789$1.07$8442.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001437749-26-029257) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for Nuo Therapeutics, Inc.

Build

Ask your agent about AURX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-26-029257"
Ask your agent
Use Arkolith to summarize insider buying and selling at Nuo Therapeutics, Inc.
over the last 90 days and cite the filings.